<DOC>
	<DOCNO>NCT00593736</DOCNO>
	<brief_summary>The purpose study evaluate ability ramelteon , daily ( QD ) , advance timing sleep individual delay sleep phase syndrome .</brief_summary>
	<brief_title>Efficacy Ramelteon Speeding Up Sleep Subjects With Delayed Sleep Phase Syndrome</brief_title>
	<detailed_description>Delayed sleep phase syndrome common circadian disorder adolescent adults condition report onset symptom childhood adolescence . Delayed Sleep Phase Syndrome involve chronic mismatch usual daily schedule require individual 's environment circadian sleep wake pattern . Individuals suffer delayed Sleep Phase Syndrome experience great difficulty attempt fall asleep 1-2 , later , well rise acceptable hour morning despite completely normal sleep architecture sleep duration . Delayed Sleep Phase Syndrome sleep disorder result dysregulation circadian sleep-wake rhythm . Delayed Sleep Phase Syndrome often cause severe insomnia associate excessive daytime sleepiness , major depressive disorder severe disruption education , work social functioning . Its major symptom extreme difficulty initiate sleep conventional hour wake time morning school work . Ramelteon selective melatonin type 1 ( MT1 ) type 2 ( MT2 ) receptor agonist . The purpose study evaluate ability ramelteon advance time sleep individual delay sleep phase syndrome . The effect ramelteon analyze base collection information post-sleep questionnaire complete participant , data collect polysomnography sleep clinic setting . Total participation time involve study approximately 7 week .</detailed_description>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Sleep Disorders , Circadian Rhythm</mesh_term>
	<criteria>Females childbearing potential sexually active must agree use adequate contraception screen throughout duration study . Must diagnosis Delayed Sleep Phase Syndrome accord International Classification Sleep Disorders criteria least 3 month . Based sleep history , subject 's habitual sleep time 3 hour later desire sleep time . Must self report insomnia define per sleep history sleep latency least 45 minute attempt sleep desire sleep time require work school schedule . The subjective sleep latency via Post sleep questionnaire outpatient screen period must great equal 45 minute every work night school night provide subject go bed desire sleep time . During single blind placebo runin Polysomnography screen night , subject instruct go bed desire bed time must demonstrate difficulty fall asleep base follow criterion : During Polysomnography screen night subject go bed desire sleep time The average total wake time Is good health determine medical psychiatric history , physical examination , Electrocardiogram , serum chemistry hematology . Is able complete selfrating scale via interactive voice response system , touch tone phone . Is willing comply study procedure restriction fix sleep time wake time study attend regularly schedule clinic visit specify protocol . Has body mass index 18 34 kg/m2 , inclusive . Has negative urine test result select substance abuse ( include alcohol ) . Has negative test result hepatitis B surface antigen hepatitis C virus antibody history human immunodeficiency virus . Has use pharmacological sleep assistance 4 times/week 3 month prior Initial Screening . Must discontinue use pharmacological sleep aid begin 1 week prior Visit 2 duration trial . Has know hypersensitivity ramelteon related compound , include melatonin melatoninrelated compound 5hydroxytryptophan . Has participate investigational study and/or take investigational drug within 30 day 5 halflives prior first dose study medication , whichever longer . Has fly across great 3 time zone within past 3 month prior administration study medication . Has sleep schedule change require employment ( eg , shift worker ) within 3 month prior administration study medication . Has participate weight loss program substantially alter exercise routine within 30 day prior administration study medication . Has history alcohol abuse within past 12 month , define Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision , regularly consume 14 alcoholic drink per week consumes alcoholic drink within 24 hour Screening Visit . Has history drug abuse within past 12 month . Has current , clinically significant neurological ( include cognitive ) , hepatic , renal , endocrine , cardiovascular , gastrointestinal , pulmonary , hematological , metabolic disease , determine investigator . Has probable current diagnosis another circadian rhythm disorder sleep disorder Delayed Sleep Phase Syndrome primary cause insomnia . Had apnea hypopnea index great 10 first night Polysomnography Screening . Has periodic limb movement sleep arousal index great 10 see first night Polysomnography screening . Has positive urine drug screen breathalyzer test . Has ever history seizure ; sleep apnea , restless leg syndrome , chronic obstructive pulmonary disease , fibromyalgia , positive test result aforementioned ailment screen Polysomnography , schizophrenia , bipolar disorder , mental retardation , cognitive disorder . Has history psychiatric disorder ( include anxiety depression ) within past 12 month . Smokes 3 cigarette per day use tobacco product nightly awakening . Routinely consumes caffeine include coffee , tea and/or caffeinecontaining beverage food average 600 mg caffeine per day . Has use central nervous system drug medication , include use treat psychiatric disorder , know affect sleep/wake function within 1 week whichever longer prior administration single blind study drug . Used melatonin , drugs/supplements know affect sleep/wake function within 1 week ( 5 half life drug ) whichever long prior first dose single blind medication . Is required take intend continue take disallowed medication , prescription medication , herbal treatment overthe counter medication may interfere evaluation study medication , include : Anxiolytics Hypnotics Antidepressants Anticonvulsants Sedating H1 antihistamine Systemic steroid Respiratory stimulant Decongestants Antipsychotics Muscle relaxant Overthecounter prescription diet aid Narcotic analgesic Beta Blockers St. John 's wort Kava kava Ginkgo biloba Modafinil Coumadin Heparin Melatonin drug supplement know affect sleep/wake function prohibit within 1 week first dose study medication entire study . Has clinically important abnormal finding determine medical history , physical examination , Electrocardiogram , clinical laboratory test determine investigator . Has positive hepatitis panel include anti Hepatitis A Virus , hepatitis B surface antigen anti hepatitis C virus . Has additional condition ( ) investigator 's opinion would : Affect sleep/wake function Prohibit subject completing study , Not best interest subject . Exhibits placebo response singleblinded placebo run period . Individuals habitual sleep time later 4:00 include study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Delayed sleep phase syndrome ; drug therapy</keyword>
</DOC>